Tate & Lyle study of low-, no-calorie sweeteners finds positive or no impact on human gut microbiota
A new, first-of-its-kind study has identified unique and potentially beneficial interactions between certain low and no calorie sweeteners, including stevia, and the human gut microbiota. Tate & Lyle PLC partnered with Cryptobiotix, pioneers in preclinical gastrointestinal research, on the study.
Dr. Davide Risso, molecular biology specialist and Tate & Lyle’s Head of Nutrition Research, led the project to explore the potential impact of certain low- and no-calorie sweeteners on the gut environment in both healthy individuals and those with type 2 diabetes.